Latest news
FDA Pre-NDA Progress On Azetukalner Could Be A Game Changer For Xenon Pharmaceuticals (XENE) - simplywall.stsimplywall.st · Fri, 07 Aug 2026 18:52:11 GMTPVLA: Advanced NDA submission and clinical pipeline with $250.6M cash; net loss widened to $21.9M - TradingViewTradingView · Tue, 04 Aug 2026 12:08:12 GMT